Diabetic neuropathy: A cross-sectional study of the relationships among tests of neurophysiology

Diabetes Care

Volumn 33, Issue 12, 2010, Pages 2629-2634

  Gibbons, Christopher H ^a   Freeman, Roy ^a   Veves, Aristidis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NERVE; AXOPLASM FLOW; BLOOD FLOW; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COLD SENSATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HEAT SENSATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHY SYMPTOM SCORE; NEUROPHYSIOLOGY; PHYSICAL EXAMINATION; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SENSORY SYSTEM EXAMINATION; VALSALVA MANEUVER;

ADULT; CROSS-SECTIONAL STUDIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NEUROPHYSIOLOGY;

EID: 79951719238     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0763     Document Type: Article

References (25)

1. Albers JW, Brown MB, Sima AA, Greene DA. Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial. Neurology 1996;46:85-91 (Pubitemid 26156107)
2. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-880
3. Freeman R. Autonomic peripheral neuropathy. Lancet 2005;365:1259-1270
4. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 2001;24:344-349 (Pubitemid 32119136)
5. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898-904 (Pubitemid 36348918)
6. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007;115:387-397 (Pubitemid 46148513)
7. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23:606-611 (Pubitemid 30321538)
8. Bril V, Ellison R, Ngo M, Bergstrom B, Raynard D, Gin H. Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group [see comments] Muscle Nerve 1998;21:1368-1373
9. Bril V, Kojic J, Ngo M, Clark K. Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies. Diabetes Care 1997;20:1360-1362 (Pubitemid 27366807)
10. Caselli A, Spallone V, Marfia GA, Battista C, Pachatz C, Veves A, Uccioli L. Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction. J Neurol Neurosurg Psychiatry 2006;77:927-932 (Pubitemid 44174076)
11. Veves A, Uccioli L, Manes C, Van Acker K, Komninou H, Philippides P, Katsilambros N, De Leeuw I, Menzinger G, Boulton AJ. Comparison of risk factors for foot problems in diabetic patients attending teaching hospital outpatient clinics in four different European states. Diabet Med 1994;11:709-713
12. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993;16:1187-1189 (Pubitemid 23215408)
13. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabetes Res Clin Pract 1995;29:37-42
14. Yarnitsky D. Quantitative sensory testing [see comments]. Muscle Nerve 1997;20:198-204 (Pubitemid 27061533)
15. Hilz MJ, Stemper B, Axelrod FB, Kolodny EH, Neundörfer B. Quantitative thermal perception testing in adults. J Clin Neurophysiol 1999;16:462-471 (Pubitemid 29496470)
16. Gibbons C, Freeman R. The evaluation of small fiber function - autonomic and quantitative sensory testing. Neurol Clin 2004;22:683-702, vii
17. Low PA. Testing the autonomic nervous system. Semin Neurol 2003;23:407-421 (Pubitemid 38437512)
18. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 2009;94:2157-2163
19. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-463
20. Dyck PJ, Litchy WJ, Daube JR, Harper CM, Dyck PJ, Davies J, O'Brien PC. Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 2003;27:202-210 (Pubitemid 36169332)
21. Kincaid JC, Price KL, Jimenez MC, Skljarevski V. Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes. Muscle Nerve 2007;36:821-827 (Pubitemid 350252925)
22. Freeman R, Chase KP, Risk MR. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy. Neurology 2003;60:465-470
23. Gordon Smith A, Robinson Singleton J. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006;242:9-14
24. Vincent AM, Hinder LM, Pop-Busui R, Feldman EL. Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst 2009;14:257-267
25. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009;58:1634-1640